The statement by Dr. Meinrad Lugan (BVMed CEO) on this year's autumn survey of the German Medical Technology Association (Bundesverband Medizintechnologie e.V.) highlights not only the good export ratio and stable domestic sales, but also concerns about the implementation of regulations.
The sales of medtech companies in the German market show an adjusted sales growth of 4.2 percent compared to 2.8 percent in the previous year. These figures can be compared with the revenue development in 2015 (4.3 percent) and 2016 (4.0 percent), with the internationally active medtech companies growing much faster abroad (revenue growth of 5.9 percent) than in Germany.
The MDR (new regulation for medical devices) is causing medical technology companies to fear rising costs, delayed assessment procedures for developed medical devices and, as a consequence, the discontinuation of products or entire product lines. The requirements imposed by the MDR would be regarded as the greatest obstacle to the future development of the medical technology sector.
The survey of medtech companies shows:
Are you a medical technology company looking for the top candidate in the field of quality management, quality assurance or regulatory affairs? Then you are in the right place.
Are you looking for your top position in the field of Quality Assurance, Quality Management or Regulatory Affairs? Then you have come to the right place.
Our expertise in the medical technology sector is confirmed by the professional careers of our consultants and the positions we have already successfully filled.
Please feel free to contact us.
Your BESTMINDS - Team